Transaction · 0001213900-26-115985

Davidson Matt

Davidson Matt, PRES, reported a transaction classified as unknown at Azora Therapeutics, Inc. (DE) involving 524954.000000 shares. Reported holdings after the transaction were 819018.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

unknownSEC transaction code CPRES
AZRAzora Therapeutics, Inc. (DE)
Trade date
Nov 02, 2026
Filing date
Nov 04, 2026
View on SEC Insider profile
Disclosed valueUnknownShares × reported price
Shares traded524kPrice unknown
Holdings after819kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

AZR price since this filing

Daily closing prices, with the filing date and available return windows
AZR · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
unknown
Code C
Identifier
0001213900-26-115985
Common Stock
Transaction date
Nov 02, 2026
Filed Nov 04, 2026, 09:54 PM · 2d delay
Shares
524,954 sh
Price unknown
Estimated value
—
Computed from shares × price
Holdings after
819,018 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Large Holdings Increase
Filing-only score

+2 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
  • missing_price-8 points

    price_cents is null

    Missing price reduces confidence in value-based signals.
Missing facts
  • price_cents
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President and CEO

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Subject to certain beneficial ownership and other limits set forth in the Certificate of Designation of the Series A Preferred Stock, each share of Series A Preferred Stock converted into 1,000 shares…

  2. F2

    The Series A Preferred Stock converted automatically within three days of Issuer's stockholders approving a proposal for the issuance of Issuer common stock upon conversion of the Series A Preferred S…

  3. F3

    The Reporting Person serves as co-trustee of the Matt and Alli Davidson Trust.

Original filing · 0001213900-26-115985
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

AZR